Corticosteroids worsen proteinuria and increase intraglomerular signaling by NF-κB in a model of membranous glomerulonephritis

Nephron - Experimental Nephrology

Volumn 116, Issue 2, 2010, Pages

  Mudge, Stuart J ^a   Paizis, Kathy ^a   Auwardt, Russell B ^a   Levidiotis, Vicki ^a   Fraser, Scott A ^a   Power, David A ^a  

^a AUSTIN HEALTH   (Australia)

Author keywords

Corticosteroids; Membranous glomerulonephritis; NF B; Passive Heymann nephritis

Indexed keywords

DEXAMETHASONE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 1BETA; MESSENGER RNA; PROTEIN P50; PYRROLIDINE DITHIOCARBAMATE; SODIUM CHLORIDE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DRUG EFFECT; DRUG EFFICACY; ENZYME ACTIVATION; ENZYME INHIBITION; GENE EXPRESSION; GLOMERULUS; HEYMANN NEPHRITIS; IMMUNE RESPONSE; LYMPHOCYTIC INFILTRATION; MALE; MEMBRANOUS GLOMERULONEPHRITIS; NONHUMAN; PASSIVE HEYMANN NEPHRITIS; PREDICTION; PRIORITY JOURNAL; PROTEIN LOCALIZATION; PROTEINURIA; RAT; SIGNAL TRANSDUCTION; T LYMPHOCYTE;

ANIMALS; DEXAMETHASONE; DISEASE MODELS, ANIMAL; GLOMERULONEPHRITIS, MEMBRANOUS; INTERLEUKIN-1BETA; KIDNEY GLOMERULUS; MALE; NF-KAPPA B; PROTEINURIA; PYRROLIDINES; RATS; RATS, SPRAGUE-DAWLEY; RNA, MESSENGER; SHEEP; SIGNAL TRANSDUCTION; THIOCARBAMATES;

EID: 77953919802     PISSN: 16602129     EISSN: None     Source Type: Journal    
DOI: 10.1159/000317128     Document Type: Article

References (29)

1. Wasserstein A: Membranous glomerulone-phritis. J Am Soc Nephrol 1997; 8:664-674.
2. 2 in passive Hey-mann nephritis. Proc Soc Exp Biol Med 1997; 214: 167-172.
3. Kerjaschki D, Neale TJ: Molecular mecha-nisms of glomerular injury in rat experimen-tal membranous nephropathy (Heymann nephritis). J Am Soc Nephrol 1996; 7:2518-2526.
4. Salant D, Cybulsky A: Experimental glomer-ulonephritis. Methods Enzymol 1988; 162: 421-461.
5. Salant D, Quigg R, Cybulsky A: Heymann nephritis: mechanism of renal injury. Kidney Int 1989; 35: 976-984.
6. Neale TJ, Ojha PP, Exner M, Poczewski H, Ruger B, Witztum JL, Davis P, Kerjaschki D: Proteinuria in passive Heymann nephritis is associated with lipid peroxidation and for-mation of adducts on type IV collagen. J Clin Investig 1994; 94: 1577-1584.
7. Stahl RA, Adler S, Baker PJ, Chen YP, Pritzl PM, Couser WG: Enhanced glomerular prostaglandin formation in experimental membranous nephropathy. Kidney Int 1987; 31:1126-1131.
8. Kilgore KS, Schmid E, Shanley TP, Flory CM, Maheswari V, Tramontini NL, Cohen H, Ward PA, Friedl HP, Warren JS: Sublytic concentrations of the membrane attack com-plex of complement induce endothelial inter-leukin-8 and monocyte chemoattractant protein-1 through nuclear factor-κB activa-tion. Am J Pathol 1997; 150:2019-2031.
9. Karin M, Lin A: NF-κB at the crossroads of life and death. Nat Immunol 2007; 3:221-227.
10. Auphan N, DiDonato JA, Rosette C, Helm-berg A, Karin M: Immunosuppression by glucocorticoids: inhibition of NF-κB activi-ty through induction of IκB synthesis. Science 1995; 270:286-290.
11. Auwardt RB, Mudge SJ, Chen CG, Power DA: Regulation of NF-κB by corticosteroids in rat mesangial cells. J Am Soc Nephrol 1998; 9: 1620-1628.
12. Sakurai H, Shigemori N, Hisada Y, Ishizuka T, Kawashima K, Sugita T: Suppression of NF-κB and AP-1 activation by glucocorti-coids in experimental glomerulonephritis in rats: molecular mechanisms of anti-nephrit-ic action. Biochim Biophys Acta 1997; 1362: 252-262.
13. Seto M, Kim S, Yoshifusa H, Nakamura Y Masuda T, Hamaguchi A, Yamanaka S, Iwao H: Effects of prednisolone on glomerular sig-nal transduction cascades in experimental glomerulonephritis. J Am Soc Nephrol 1998; 9: 1367-1376.
14. Mudge SJ, Paizis K, Auwardt RB, Thomas RJ, Power DA: Activation of nuclear factor-κB by podocytes in the autologous phase of passive Heymann nephritis. Kidney Int 2001; 59: 923-931.
15. Arai T, Morimoto K, Masaoka H, Kaneko O, Mera J, Kojima K, Nagase M, Kobayashi S, Ohtake T, Hishida A: Ultrastructural back-ground of albuminuria in rats with passive Heymann nephritis. Nephrol Dial Trans-plant 1997; 12:2542-2548.
16. Paizis K, Kirkland G, Polihronis M, Katerelos M, Kanellis J, Power, DA: Heparin-binding epidermal growth factor-like growth factor in experimental models of membranous and minimal change nephropathy. Kidney Int 1998; 53: 1162-1171.
17. Schreiber E, Matthias P, Muller MM, Schaff-ner W: Rapid detection of octamer binding proteins with 'mini-extracts', prepared from a small number of cells. Nucleic Acids Res 1989; 17:6419.
18. Southby J, O'Keefe LM, Martin TJ, Gillespie MT: Alternative promoter usage and mRNA splicing pathways for parathyroid hormone-related protein in normal tissues and tu-mours. Br J Cancer 1995; 72:702-707.
19. Hancock WW, Becker GJ, Atkins RC: A com-parison of fixatives and immunohistochem-ical technics for use with monoclonal anti-bodies to cell surface antigens. Am J Clin Pathol 1982; 78:825-831.
20. Lipschutz JH: Molecular development of the kidney: a review of the results of gene disrup-tion studies. Am J Kidney Dis 1998; 31:383-397.
21. Wolfish MN: Increased proteinuria due to steroid therapy in chronic renal disease. J Pe-diatr 1969: 75: 524.
22. Heymann W, Grupe WE: Increase in pro-teinuria due to steroid medication in chronic renal disease. J Pediatr 1969; 74: 356-363.
23. Ha IS, Um EY, Jung HR, Park HW, Cheong HI, Choi Y: Glucocorticoid diminishes vas-cular endothelial growth factor and exacer-bates proteinuria in rats with mesangial pro-liferative glomerulonephritis. Am J Kidney Dis 2002; 39: 1001-1010.
24. Garcia DL, Rennke HG, Brenner BM, Ander-son S: Chronic glucocorticoid therapy am-plifies glomerular injury in rats with renal ablation. J Clin Invest 1987; 80:867-874.
25. Ou ZL, Nakayama K, Natori Y, Doi N, Saito T: Effective methylprednisolone dose in ex-perimental crescentic glomerulonephritis. Am J Kidney Dis 2001; 37: 411-417.
26. Trachtman H, Del Pizzo R, Valderrama E, Gauthier B: The renal functional and struc-tural consequences of corticosteroid and an-giotensin-converting enzyme inhibitor ther-apy in chronic puromycin aminonucleoside nephropathy. Pediatr Nephrol 1990; 4:501-504.
27. Muraoka K, Fujimoto K, Sun X, Yoshioka K, Shimizu K, Yagi M, Bose H Jr, Miyazaki I, Yamamoto K: Immunosuppressant FK506 induces interleukin-6 production through the activation of transcription factor nuclear factor-κB. Implications for FK506 nephropathy. J Clin Invest 1996; 97:2433-2439.
28. Gregoire F: Oxidative metabolism of the nor-mal rat glomerulus. Kidney Int 1975; 7:86-93.
29. Norgaard JO: A new method for the isolation of ultrastructurally preserved glomeruli. Kidney Int 1976; 9: 278-285.